RU2322263C2 - Система продолжительного высвобождения растворимого лекарственного средства - Google Patents

Система продолжительного высвобождения растворимого лекарственного средства Download PDF

Info

Publication number
RU2322263C2
RU2322263C2 RU2004117848/15A RU2004117848A RU2322263C2 RU 2322263 C2 RU2322263 C2 RU 2322263C2 RU 2004117848/15 A RU2004117848/15 A RU 2004117848/15A RU 2004117848 A RU2004117848 A RU 2004117848A RU 2322263 C2 RU2322263 C2 RU 2322263C2
Authority
RU
Russia
Prior art keywords
drug
pharmaceutical composition
release
micelle
polymer
Prior art date
Application number
RU2004117848/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2004117848A (ru
Inventor
Виктори РОДЖЕРС (US)
Виктория РОДЖЕРС
Филип Дж. М. ДОР (US)
Филип Дж. М. ДОР
Джозеф А. ФИКС (US)
Джозеф А. ФИКС
Хироюки КОДЗИМА (JP)
Хироюки КОДЗИМА
Казухиро САКО (JP)
Казухиро САКО
Original Assignee
Астеллас Фарма, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Астеллас Фарма, Инк. filed Critical Астеллас Фарма, Инк.
Publication of RU2004117848A publication Critical patent/RU2004117848A/ru
Application granted granted Critical
Publication of RU2322263C2 publication Critical patent/RU2322263C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU2004117848/15A 2001-11-13 2002-11-12 Система продолжительного высвобождения растворимого лекарственного средства RU2322263C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US787701A 2001-11-13 2001-11-13
US10/007,877 2001-11-13

Publications (2)

Publication Number Publication Date
RU2004117848A RU2004117848A (ru) 2005-05-27
RU2322263C2 true RU2322263C2 (ru) 2008-04-20

Family

ID=21728577

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2004117848/15A RU2322263C2 (ru) 2001-11-13 2002-11-12 Система продолжительного высвобождения растворимого лекарственного средства

Country Status (10)

Country Link
EP (1) EP1443901A4 (ko)
JP (2) JP4882200B2 (ko)
KR (2) KR101132969B1 (ko)
CN (1) CN100534531C (ko)
AU (1) AU2002348279C1 (ko)
CA (1) CA2466657C (ko)
MX (1) MXPA04004544A (ko)
PL (1) PL374280A1 (ko)
RU (1) RU2322263C2 (ko)
WO (1) WO2003041656A2 (ko)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050042289A1 (en) * 2003-04-29 2005-02-24 Yamanouchi Pharma Technologies, Inc. Tablets and methods for modified release of hydrophylic and other active agents
JP4822092B2 (ja) * 2003-09-01 2011-11-24 大正製薬株式会社 Ｗ／ｏ／ｗ型複合エマルション
MXPA06003769A (es) * 2003-11-04 2006-07-03 Shire Lab Inc Liberacion sostenida de moleculas farmacologicamente activas cargadas positivamente a partir de una matriz que contiene polimeros con atomos de oxigeno polarizados.
US8197846B2 (en) 2003-11-10 2012-06-12 Astellas Pharma Inc. Sustained release pharmaceutical composition
KR100638041B1 (ko) * 2003-12-24 2006-10-23 주식회사 삼양사 수용성 약물의 경구투여용 나노입자 조성물 및 그의제조방법
CA2755692A1 (en) * 2009-03-25 2010-09-30 Aska Pharmaceutical Co., Ltd. Solid preparation
KR101319420B1 (ko) * 2011-03-18 2013-10-17 한남대학교 산학협력단 서방형 방출이 가능한 수용성 양이온 약물 전달 시스템
WO2012140674A1 (en) * 2011-04-11 2012-10-18 Council Of Scientific & Industrial Research Surface induced disassembly of nano containers
CN102977413B (zh) * 2011-09-07 2015-05-13 江南大学 聚合物复合制备胶束的一种新方法
CN103083222B (zh) * 2011-10-28 2015-08-19 江南大学 一锅法制备三组分聚合物胶束
JP6041823B2 (ja) 2013-03-16 2016-12-14 ファイザー・インク トファシチニブの経口持続放出剤形
KR20220022829A (ko) * 2020-08-19 2022-02-28 주식회사 모든바이오 글리시리진 및 수용성 약물을 포함하는 나노 입자, 이를 포함하는 약제학적 조성물 및 이들의 제조 방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE32806B1 (en) * 1968-05-21 1973-12-12 American Home Prod Sustained release drug composition
JPS6410466A (en) * 1987-07-01 1989-01-13 Brother Ind Ltd Data recording and reproducing method for magnetic disk
US5219563A (en) * 1988-05-11 1993-06-15 Glaxo Group Limited Drug adsorbates
DK0661045T3 (da) * 1992-09-18 2002-10-28 Yamanouchi Pharma Co Ltd Hydrogelpræparat med forsinket frigivelse
US5788959A (en) * 1995-04-24 1998-08-04 University Of Maryland, Baltimore County Drug delivery device and method for employing the same
US6221399B1 (en) * 1995-08-17 2001-04-24 Csir Method of making controlled release particles of complexed polymers
IT1297461B1 (it) * 1997-10-29 1999-12-17 Ciocca Maurizio Preparazione di compresse a rilascio controllato a base di complessi tra carragenano e farmaci basici solubili
EP1281397A1 (en) * 1998-09-14 2003-02-05 Ranbaxy Laboratories Limited Orally administered controlled drug delivery system providing temporal and spatial control
US6287599B1 (en) * 2000-12-20 2001-09-11 Shire Laboratories, Inc. Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
AR034517A1 (es) * 2001-06-21 2004-02-25 Astrazeneca Ab Formulacion farmaceutica

Also Published As

Publication number Publication date
CA2466657A1 (en) 2003-05-22
CN100534531C (zh) 2009-09-02
JP4894958B2 (ja) 2012-03-14
CA2466657C (en) 2011-02-01
MXPA04004544A (es) 2005-03-31
WO2003041656A2 (en) 2003-05-22
JP2011068700A (ja) 2011-04-07
JP4882200B2 (ja) 2012-02-22
RU2004117848A (ru) 2005-05-27
KR101016619B1 (ko) 2011-02-23
EP1443901A2 (en) 2004-08-11
KR20050044424A (ko) 2005-05-12
PL374280A1 (en) 2005-10-03
AU2002348279C1 (en) 2008-09-04
EP1443901A4 (en) 2010-06-16
AU2002348279B2 (en) 2008-01-24
KR101132969B1 (ko) 2012-04-09
KR20100123779A (ko) 2010-11-24
JP2005508995A (ja) 2005-04-07
WO2003041656A3 (en) 2003-10-23
CN1612726A (zh) 2005-05-04

Similar Documents

Publication Publication Date Title
US20040091528A1 (en) Soluble drug extended release system
JP4894958B2 (ja) 水溶性薬物徐放化技術
TWI324075B (en) Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
EP1843755B1 (en) Gastric retention and controlled release delivery system
US6881420B2 (en) Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation
JP3140465B2 (ja) ハイドロゲル徐放性製剤
US6419954B1 (en) Tablets and methods for modified release of hydrophilic and other active agents
US20120321711A1 (en) Direct compression polymer tablet core
CA2387915C (en) Direct compression polymer tablet core
HRP20010187A2 (en) Orally administered controlled drug delivery system providing temporal and spatial control
JP2005506998A (ja) インビトロ崩壊試験データを用いた侵食性胃保持性経口投薬形態の処方
WO2002070021A1 (en) Gastric delivery of antineoplastic agents and methods of treatment via inhibition of cancer cell using them
PL187764B1 (pl) Tabletki farmaceutyczne o kontrolowanym uwalnianiu zawierające nośnik oparty na sieciowanej amylozie i hydroksypropylometylocelulozie oraz zastosowanie hydroksypropylometylocelulozy
AU2002348279A1 (en) Soluble drug extended release system
US20060188563A1 (en) Medicinal oral preparations for colon delivery, medicinal oral preparations for treating colon cancer and medicinal oral preparations for treating colitis
EP1502587B1 (en) Sustained release formulation for Venlafaxine hydrochloride
EP1512394B1 (en) Universal controlled-release composition comprising chitosan
JP3598049B2 (ja) ハイドロゲル徐放性製剤
Shinde et al. A novel approach of gastroretentive drug delivery: in situ gel
Principal Oral In-Situ Gel: A Review

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20141113